Sten Olsson
Impact in
- Toxicology top 0.02%
- Pharmacovigilance and Adverse Drug Reactions
- Geriatrics and Gerontology top 1%
- Pharmaceutical Practices and Patient Outcomes
Papers in
- Toxicology 31
- Pharmacovigilance and Adverse Drug Reactions 31
- Co-authors
- Shanthi PalMarie LindquistI. Ralph EdwardsAndrew BateAnders LansnerRoland OrreRivelilson Mendes de FreitasMary Couper
- Journals
- Drug Safety (16 papers)Malaria Journal (3 papers)Pharmacoepidemiology and Drug Safety (2 papers)The Lancet (2 papers)Value in Health (2 papers)
- Partner nations
- SwedenSwitzerlandNetherlands
In The Last Decade
Sten Olsson
47 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 141
- Toxicology 1.6k
- Geriatrics and Gerontology 284
- Applied Microbiology and Biotechnology 66
- Pharmacology 473
- Pharmacology 212
Countries citing papers authored by Sten Olsson
This map shows the geographic impact of Sten Olsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sten Olsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sten Olsson more than expected).
Fields of papers citing papers by Sten Olsson
This network shows the impact of papers produced by Sten Olsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sten Olsson. The network helps show where Sten Olsson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sten Olsson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 54 | |
| 2 | 2020 | 1 | |
| 3 | 2020 | 4 | |
| 4 | 2020 | 4 | |
| 5 | 2018 | 14 | |
| 6 | 2017 | 14 | |
| 7 | 2015 | 27 | |
| 8 | 2015 | 6 | |
| 9 | 2015 | 17 | |
| 10 | 2014 | 26 | |
| 11 | 2014 | 34 | |
| 12 | 2013 | 172 | |
| 13 | 2011 | 113 | |
| 14 | 2011 | 30 | |
| 15 | 2007 | 8 | |
| 16 | Administration: The who international pharmacovigilance programme and the Uppsala Monitoring Centre | 2007 | 2 |
| 17 | 2003 | 138 | |
| 18 | 1998 | 114 | |
| 19 | 1988 | 20 | |
| 20 | 1985 | 8 |
About Sten Olsson
Sten Olsson is a scholar working on Toxicology, Applied Microbiology and Biotechnology, Geriatrics and Gerontology, Economics and Econometrics and Pediatrics, Perinatology and Child Health, having authored 47 papers that have together received 2.5k indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (31 papers), Pharmaceutical Economics and Policy (21 papers), Pharmaceutical studies and practices (11 papers), Pharmaceutical Quality and Counterfeiting (10 papers), Drug-Induced Adverse Reactions (9 papers), Tuberculosis Research and Epidemiology (6 papers), Computational Drug Discovery Methods (5 papers) and Pharmaceutical Practices and Patient Outcomes (5 papers). The work is most often cited by research in Toxicology (1.6k citations), Geriatrics and Gerontology (284 citations), Applied Microbiology and Biotechnology (66 citations), Pharmacology (473 citations) and Pharmacology (212 citations). Sten Olsson has collaborated with scholars based in Sweden, Switzerland and Netherlands. Frequent co-authors include Shanthi Pal, Marie Lindquist, I. Ralph Edwards, Andrew Bate, Anders Lansner, Roland Orre, Rivelilson Mendes de Freitas, Mary Couper, Kees van Grootheest and Chris Duncombe. Their work appears in journals such as Drug Safety, Malaria Journal, Pharmacoepidemiology and Drug Safety, The Lancet and Value in Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.